1. Blockade of CXCR6 reduces invasive potential of gastric cancer cells through inhibition of AKT signaling
    Ya Li et al, 2015, International Journal of Immunopathology and Pharmacology CrossRef
  2. The chemokine CXCL16 modulates neurotransmitter release in hippocampal CA1 area
    Maria Amalia Di Castro et al, 2016, Scientific Reports CrossRef
  3. Synthesizing Molecular and Immune Characteristics to Move Beyond WHO Grade in Meningiomas: A Focused Review
    Nivedha V. Kannapadi et al, 2022, Frontiers in Oncology CrossRef
  4. Structure and Function of Ligand CX3CL1 and its Receptor CX3CR1 in Cancer
    Xinjie Lu, 2022, Current Medicinal Chemistry CrossRef
  5. Gene expression analysis during progression of malignant meningioma compared to benign meningioma
    Andrea D. Maier et al, 2022, Journal of Neurosurgery CrossRef
  6. Human Monocyte Heterogeneity as Revealed by High-Dimensional Mass Cytometry
    Anouk A.J. Hamers et al, 2019, Arteriosclerosis, Thrombosis, and Vascular Biology CrossRef
  7. CXC chemokine ligand 16: a Swiss army knife chemokine in cancer
    Arezoo Gowhari Shabgah et al, 2021, Expert Reviews in Molecular Medicine CrossRef
  8. “Inverse signaling” of the transmembrane chemokine CXCL16 contributes to proliferative and anti-apoptotic effects in cultured human meningioma cells
    Kirsten Hattermann et al, 2016, Cell Communication and Signaling CrossRef
  9. MiR-451 inhibits cell growth and invasion by targeting CXCL16 and is associated with prognosis of osteosarcoma patients
    Fei Zhang et al, 2015, Tumor Biology CrossRef
  10. Down regulation of Akirin-2 increases chemosensitivity in human glioblastomas more efficiently than Twist-1
    Sebastian Krossa et al, 2015, Oncotarget CrossRef
  11. The Role of CXCL16 in the Pathogenesis of Cancer and Other Diseases
    Jan Korbecki et al, 2021, International Journal of Molecular Sciences CrossRef
  12. The Tumor Immune Microenvironment in Primary CNS Neoplasms: A Review of Current Knowledge and Therapeutic Approaches
    Anita L. Kalluri et al, 2023, International Journal of Molecular Sciences CrossRef
  13. Intracranial Meningiomas: A 30-Year Experience and Literature Review
    H. Maximilian Mehdorn, 2016, Advances and Technical Standards in Neurosurgery CrossRef
  14. Single-cell RNA transcriptome analysis of CNS immune cells reveals CXCL16/CXCR6 as maintenance factors for tissue-resident T cells that drive synapse elimination
    Sarah F. Rosen et al, 2022, Genome Medicine CrossRef
  15. The Chemokine Receptor CXCR6 Evokes Reverse Signaling via the Transmembrane Chemokine CXCL16
    Vivian Adamski et al, 2017, International Journal of Molecular Sciences CrossRef
  16. Microglia–blood vessel interactions: a double-edged sword in brain pathologies
    Nevenka Dudvarski Stankovic et al, 2016, Acta Neuropathologica CrossRef
  17. Matrix metalloproteinase‐1‐mediated mesenchymal stem cell tumor tropism is dependent on crosstalk with stromal derived growth factor 1/C‐X‐C chemokine receptor 4 axis
    Ivy A. W. Ho et al, 2014, The FASEB Journal CrossRef
  18. Meningioma–Brain Crosstalk: A Scoping Review
    Josefine de Stricker Borch et al, 2021, Cancers CrossRef